GFFFX
Price
$84.45
Change
-$0.41 (-0.48%)
Updated
Dec 17 closing price
RAEBX
Price
$43.02
Change
-$2.80 (-6.11%)
Updated
Dec 17 closing price
Ad is loading...

GFFFX vs RAEBX

Header iconGFFFX vs RAEBX Comparison
Open Charts GFFFX vs RAEBXBanner chart's image
American Funds Growth Fund of Amer F2
Price$84.45
Change-$0.41 (-0.48%)
VolumeN/A
CapitalizationN/A
American Funds AMCAP R2E
Price$43.02
Change-$2.80 (-6.11%)
VolumeN/A
CapitalizationN/A
GFFFX vs RAEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFFFX vs. RAEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFFFX is a Buy and RAEBX is a Hold.

FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 315B vs. RAEBX (94B). GFFFX pays higher dividends than RAEBX: GFFFX (0.67) vs RAEBX (0.00). GFFFX was incepted earlier than RAEBX: GFFFX (16 years) vs RAEBX (10 years). GFFFX (31.00) and RAEBX (31.00) have comparable annual turnover. GFFFX (250) and RAEBX (250) have matching initial minimum investment requirements. GFFFX annual gain was more profitable for investors over the last year : 35.60 vs. RAEBX (17.45). GFFFX return over 5 years is better than : 56.58 vs. RAEBX (30.53).
GFFFXRAEBXGFFFX / RAEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years10 years-
Gain YTD34.21816.184211%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets315B94B335%
Annual Yield % from dividends0.670.0028,263%
Returns for 1 year35.6017.45204%
Returns for 3 years19.100.335,730%
Returns for 5 years56.5830.53185%
Returns for 10 years99.1052.13190%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZ7.300.09
+1.25%
A2Z Cust2Mate Solutions Corp
EXPD115.92-1.86
-1.58%
Expeditors International of Washington
FIGS5.91-0.11
-1.83%
FIGS
REZI25.45-0.78
-2.97%
Resideo Technologies
CARA0.25-0.01
-3.22%
Cara Therapeutics